Mucosal administration of anti-bacterial antibody (Ab) provides long-term cross-protection against Pseudomonas aeruginosa respiratory infection

Autor: A Pitiot, M Ferreira, C Parent, C Boisseau, M Cortes, L Bouvart, N Aubrey, C Paget, N Heuzé-Vourc'H, T Secher
Rok vydání: 2022
Zdroj: 10.01 - Respiratory infections and bronchiectasis.
DOI: 10.1183/13993003.congress-2022.1818
Databáze: OpenAIRE